These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9040960)

  • 1. First human myoblast transfer therapy continues to show dystrophin after 6 years.
    Law PK; Goodwin TG; Fang Q; Hall TL; Quinley T; Vastagh G; Duggirala V; Larkin C; Florendo JA; Li L; Jackson T; Yoo TJ; Chase N; Neel M; Krahn T; Holcomb R
    Cell Transplant; 1997; 6(1):95-100. PubMed ID: 9040960
    [No Abstract]   [Full Text] [Related]  

  • 2. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy.
    Neumeyer AM; Cros D; McKenna-Yasek D; Zawadzka A; Hoffman EP; Pegoraro E; Hunter RG; Munsat TL; Brown RH
    Neurology; 1998 Aug; 51(2):589-92. PubMed ID: 9710042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy.
    Law PK; Bertorini TE; Goodwin TG; Chen M; Fang QW; Li HJ; Kirby DS; Florendo JA; Herrod HG; Golden GS
    Lancet; 1990 Jul; 336(8707):114-5. PubMed ID: 1697393
    [No Abstract]   [Full Text] [Related]  

  • 5. Myoblast transfer in Duchenne muscular dystrophy.
    Karpati G; Ajdukovic D; Arnold D; Gledhill RB; Guttmann R; Holland P; Koch PA; Shoubridge E; Spence D; Vanasse M
    Ann Neurol; 1993 Jul; 34(1):8-17. PubMed ID: 8517684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoblast transfer therapy for Duchenne muscular dystrophy.
    Law PK; Goodwin TG; Fang QW; Chen M; Li HJ; Florendo JA; Kirby DS
    Acta Paediatr Jpn; 1991 Apr; 33(2):206-15. PubMed ID: 1957647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.
    Tremblay JP; Malouin F; Roy R; Huard J; Bouchard JP; Satoh A; Richards CL
    Cell Transplant; 1993; 2(2):99-112. PubMed ID: 8143083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoblast transfer in DMD: problems in the interpretation of efficiency.
    Karpati G; Holland P; Worton RG
    Muscle Nerve; 1992 Oct; 15(10):1209-10. PubMed ID: 1406777
    [No Abstract]   [Full Text] [Related]  

  • 9. Human dystrophin gene transfer: genetic correction of dystrophin deficiency.
    Dickson G; Dunckley M
    Mol Cell Biol Hum Dis Ser; 1993; 3():283-302. PubMed ID: 8111543
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer.
    Morandi L; Bernasconi P; Gebbia M; Mora M; Crosti F; Mantegazza R; Cornelio F
    Neuromuscul Disord; 1995 Jul; 5(4):291-5. PubMed ID: 7580241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice.
    Huard J; Tremblay G; Verreault S; Labrecque C; Tremblay JP
    Cell Transplant; 1993; 2(2):113-8. PubMed ID: 8143077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophin cytochemistry in mdx mouse muscles injected with labeled normal myoblasts.
    Chen M; Li HJ; Fang Q; Goodwin TG; Florendo JA; Law PK
    Cell Transplant; 1992; 1(1):17-22. PubMed ID: 1344288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys.
    Law PK; Goodwin TG; Fang Q; Duggirala V; Larkin C; Florendo JA; Kirby DS; Deering MB; Li HJ; Chen M
    Cell Transplant; 1992; 1(2-3):235-44. PubMed ID: 1344295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.
    Miller RG; Sharma KR; Pavlath GK; Gussoni E; Mynhier M; Lanctot AM; Greco CM; Steinman L; Blau HM
    Muscle Nerve; 1997 Apr; 20(4):469-78. PubMed ID: 9121505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy of Duchenne muscular dystrophy.
    Fassati A; Murphy S; Dickson G
    Adv Genet; 1997; 35():117-53. PubMed ID: 9348647
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell and gene therapy in Duchenne muscular dystrophy.
    Morgan JE
    Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive therapy in Duchenne muscular dystrophy: considerations for myoblast transfer studies.
    Mendell JR
    Adv Exp Med Biol; 1990; 280():287-95. PubMed ID: 2248150
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of an ultrasound-mediated nucleic acid delivery system for treating muscular dystrophies].
    Negishi Y; Hamano N; Shiono H; Akiyama S; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
    Yakugaku Zasshi; 2012; 132(12):1383-8. PubMed ID: 23208045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoblast transfer in muscular dystrophy: panacea or pie in the sky?
    Dubowitz V
    Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene therapy for muscle diseases.
    Coovert DD; Burghes AH
    Curr Opin Neurol; 1994 Oct; 7(5):463-70. PubMed ID: 7804468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.